Lv13
52 积分 2024-09-09 加入
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
1天前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
1天前
已完结
Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 1
20天前
已完结
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy
1个月前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer A Phase II Nonrandomized Controlled Trial
1个月前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer A Phase II Nonrandomized Controlled Trial
1个月前
已完结
Camrelizumab: an investigational agent for hepatocellular carcinoma
2个月前
已完结
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
2个月前
已完结
Camrelizumab: First Global Approval
2个月前
已完结
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
4个月前
已完结
皖公网安备34019202002308
